Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

CME Outfitters

Don’t Snooze on the Latest Evidence on Excessive Daytime Sleepiness in OSA and Narcolepsy: An Expert-Guided Tour of the Sleep 2019 Annual Meeting

Access Activity

Overview / Abstract:

Residual excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) and narcolepsy is a common, debilitating condition that compromises patients' overall health, wellness, and safety. The field of sleep medicine is rapidly evolving to address the unmet needs of EDS as novel treatment options become available.

In this CME Outfitters dynamic, interactive infographic, expert faculty discuss the impact of EDS on daily functioning, highlight the efficacy of current and novel treatment strategies, and provide expert commentary assessing the data for novel treatments.


Sep 24, 2020


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME


Online, Webinar / Webcast / Video

Credits / Hours

1.0 AMA PRA Category 1 Credit(s)TM/contact hours/CEUs



Presenters / Authors / Faculty

Richard K. Bogan, MD, FCCP, FAASM
President of Bogan Sleep Consultants, LLC
Chief Medical Officer, SleepMed Inc.
Director, SleepMed of South Carolina
Associate Clinical Professor
University of South Carolina School of Medicine
Columbia, SC
Associate Clinical Professor
Medical University of South Carolina
Charleston, SC

Sponsors / Supporters / Grant Providers

Supported by an educational grant from Jazz Pharmaceuticals, Inc.

Keywords / Search Terms

CME Outfitters, LLC sleep medicine, pulmonology, sleep specialist, narcolepsy, OSA, sleep apnea, sleep disorders Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.